Mass spectrometry makes the clinical grade

A new mass spectrometry-based test identifies proteins from blood with as much accuracy and sensitivity as the antibody-based tests used clinically, researchers report. The head-to-head comparison using blood samples from cancer patients measured biomarkers, proteins whose presence identifies a disease or condition. The technique should be able to speed up development of protein-specific diagnostic tests and treatment.

Read the whole article on Science Daily

More from Science Daily